NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) — Cash Flow Reinvestment Rate
NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a Cash Flow Reinvestment Rate of 0.00x as of December 2022, reinvesting $109.43K (capex $109.43K ) from operating cash flow of $29.19 Million. Check NAMS cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
NewAmsterdam Pharma Company N.V. Ordinary Shares Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for NewAmsterdam Pharma Company N.V. Ordinary Shares across 1 annual periods. Explore NewAmsterdam Pharma Company N.V. Ordinar (NAMS) investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for NewAmsterdam Pharma Company N.V. Ordinary Shares (2022–2022)
Year-by-year capital reinvestment analysis for NewAmsterdam Pharma Company N.V. Ordinary Shares. For live market cap and broader valuation context, see NAMS company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.09x | $936.00K | $10.66 Million | $221.00K | — |